Protective Efficacy Against Tuberculosis (TB) Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)

This study has been completed.
Sponsor:
Collaborators:
University of Oxford
European and Developing Countries Clinical Trials Partnership (EDCTP)
Information provided by (Responsible Party):
Aeras
ClinicalTrials.gov Identifier:
NCT01151189
First received: June 24, 2010
Last updated: October 29, 2014
Last verified: October 2014